Systemic immune-inflammation index predicts new onset atrial fibrillation after ST elevation myocardial infarction
BIOMARKERS IN MEDICINE, cilt.15, ss.731-739, 2021 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 15
- Basım Tarihi: 2021
- Doi Numarası: 10.2217/bmm-2020-0838
- Dergi Adı: BIOMARKERS IN MEDICINE
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Chemical Abstracts Core, EMBASE, MEDLINE
- Sayfa Sayıları: ss.731-739
- Anahtar Kelimeler: atrial fibrillation, ST segment elevation myocardial infarction, systemic immune-inflammation index, ACUTE CORONARY SYNDROMES, SEGMENT ELEVATION, EUROPEAN-SOCIETY, ASSOCIATION, GUIDELINES, MANAGEMENT, RATIO, ESC
- Süleyman Demirel Üniversitesi Adresli: Evet
Özet
Aim: To investigate the predictive capacity of a systemic immune-inflammation index (SII) in detecting new onset atrial fibrillation (NOAF) following ST segment elevation myocardial infarction (STEMI). Patients & methods: A total of 402 STEMI patients were enrolled in the study. The patients were divided into two groups according to NOAF development. Results: A cut-off point of 1,228,000 for SII was identified with 60% sensitivity and 78.1% specificity to predict NOAF following STEMI. According to pairwise analysis of receiver operating characteristic curve analysis, the predictive power of SII in detecting NOAF following STEMI was similar to high-sensitive C-reactive protein, and better than neutrophil-to-lymphocyte ratio or platelet-to-lymphocyte ratio. Conclusion: SII can be used as one of the independent predictors of NOAF following STEMI.